Journal Article Summary
The article investigates the use of opportunistically collected pediatric data to evaluate existing pharmacokinetic models for risperidone, a medication commonly prescribed to children for various psychiatric conditions. Understanding how risperidone behaves in the body is crucial, as it can help tailor dosing for individual patients, especially given the drug's wide variability in how it affects different children. This study is particularly important because risperidone is frequently used in pediatric populations, yet there is limited research on its pharmacokinetics specifically in children.
In this study, researchers analyzed blood samples from 62 pediatric patients aged between 0.16 and 16.8 years, collecting a total of 103 concentrations of risperidone and 112 concentrations of its active metabolite, 9-OH-risperidone. They evaluated five published pharmacokinetic models to determine which provided the most accurate predictions of drug concentrations. The findings revealed that while all models showed similar precision in their predictions, one model demonstrated significantly less bias in predicting risperidone levels compared to others. However, none of the models were found to be fully generalizable to the pediatric population studied, indicating that further refinement is needed for effective dosing.
The study has several limitations, including the absence of genetic data that could influence drug metabolism, which may have affected the models' accuracy. Additionally, the diverse characteristics of the pediatric population, such as age and weight, could contribute to variability in drug responses. Readers should discuss the implications of these findings with healthcare professionals, particularly regarding the dosing of risperidone in children, as the current models may not fully account for individual differences. This conversation is essential to ensure safe and effective treatment plans tailored to each child's needs.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Karatza Eleni, Ganguly Samit, Hornik Chi D., Muller William J., Al-Uzri Amira, James Laura, Balevic Stephen J., Gonzalez Daniel. External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data. Frontiers in Pharmacology 2022. DOI: 10.3389/fphar.2022.817276. PMID: 35370711. PMCID: PMC8969425.
Featured Pill Pals Product
Risperidone 0.25 mg Tablets --- Generic For Risperdal --- Ajanta
Risperidone 0.25 mg Tablets — Generic For Risperdal — Ajanta is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
